TYRATyra Biosciences, Inc.

$26.23

Is the business good?

How good a business is TYRA?

Share count, year on year
+11%

Share count, year on year · shareholders own a smaller slice than a year ago

Details
Free cash flow, trailing twelve months
−$110M
Net income, trailing twelve months
−$149M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.